261 related articles for article (PubMed ID: 12654805)
1. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.
Bermúdez-Humarán LG; Langella P; Cortes-Perez NG; Gruss A; Tamez-Guerra RS; Oliveira SC; Saucedo-Cardenas O; Montes de Oca-Luna R; Le Loir Y
Infect Immun; 2003 Apr; 71(4):1887-96. PubMed ID: 12654805
[TBL] [Abstract][Full Text] [Related]
2. An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci.
Bermúdez-Humarán LG; Cortes-Perez NG; Le Loir Y; Alcocer-González JM; Tamez-Guerra RS; de Oca-Luna RM; Langella P
J Med Microbiol; 2004 May; 53(Pt 5):427-433. PubMed ID: 15096553
[TBL] [Abstract][Full Text] [Related]
3. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
Cortes-Perez NG; Lefèvre F; Corthier G; Adel-Patient K; Langella P; Bermúdez-Humarán LG
Vaccine; 2007 Sep; 25(36):6581-8. PubMed ID: 17675182
[TBL] [Abstract][Full Text] [Related]
4. Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein.
Taghinezhad-S S; Mohseni AH; Keyvani H; Razavilar V
Microb Pathog; 2019 Jan; 126():149-156. PubMed ID: 30391536
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.
Bermúdez-Humarán LG; Nouaille S; Zilberfarb V; Corthier G; Gruss A; Langella P; Issad T
Appl Environ Microbiol; 2007 Aug; 73(16):5300-7. PubMed ID: 17601816
[TBL] [Abstract][Full Text] [Related]
6. Intranasal coadministration of live lactococci producing interleukin-12 and a major cow's milk allergen inhibits allergic reaction in mice.
Cortes-Perez NG; Ah-Leung S; Bermúdez-Humarán LG; Corthier G; Wal JM; Langella P; Adel-Patient K
Clin Vaccine Immunol; 2007 Mar; 14(3):226-33. PubMed ID: 17202306
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with recombinant Lactococcus lactis NZ9000 expressing human papillomavirus type 16 E7 antigen and evaluation of its immune effects in female C57BL/6 mice.
Mohseni AH; Razavilar V; Keyvani H; Razavi MR; Khavari-Nejad RA
J Med Virol; 2019 Feb; 91(2):296-307. PubMed ID: 30192395
[TBL] [Abstract][Full Text] [Related]
8. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors.
Bermúdez-Humarán LG; Cortes-Perez NG; Lefèvre F; Guimarães V; Rabot S; Alcocer-Gonzalez JM; Gratadoux JJ; Rodriguez-Padilla C; Tamez-Guerra RS; Corthier G; Gruss A; Langella P
J Immunol; 2005 Dec; 175(11):7297-302. PubMed ID: 16301635
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection.
Hugentobler F; Di Roberto RB; Gillard J; Cousineau B
Vaccine; 2012 Aug; 30(39):5726-32. PubMed ID: 22814408
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interleukin 6 with M cell-targeting moiety produced in Lactococcus lactis IL1403 as a potent mucosal adjuvant for peroral immunization.
Li HS; Piao DC; Jiang T; Bok JD; Cho CS; Lee YS; Kang SK; Choi YJ
Vaccine; 2015 Apr; 33(16):1959-67. PubMed ID: 25738814
[TBL] [Abstract][Full Text] [Related]
11. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.
Steidler L; Robinson K; Chamberlain L; Schofield KM; Remaut E; Le Page RW; Wells JM
Infect Immun; 1998 Jul; 66(7):3183-9. PubMed ID: 9632584
[TBL] [Abstract][Full Text] [Related]
12. Mucosal and systemic immune responses elicited by recombinant Lactococcus lactis expressing a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis.
Torkashvand A; Bahrami F; Adib M; Ajdary S
Microb Pathog; 2018 Jul; 120():155-160. PubMed ID: 29738814
[TBL] [Abstract][Full Text] [Related]
13. Immunization against Leishmania major infection using LACK- and IL-12-expressing Lactococcus lactis induces delay in footpad swelling.
Hugentobler F; Yam KK; Gillard J; Mahbuba R; Olivier M; Cousineau B
PLoS One; 2012; 7(2):e30945. PubMed ID: 22348031
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunisation with recombinant Lactococcus lactis displaying either anchored or secreted forms of Proteus mirabilis MrpA fimbrial protein confers specific immune response and induces a significant reduction of kidney bacterial colonisation in mice.
Scavone P; Miyoshi A; Rial A; Chabalgoity A; Langella P; Azevedo V; Zunino P
Microbes Infect; 2007 Jun; 9(7):821-8. PubMed ID: 17540603
[TBL] [Abstract][Full Text] [Related]
15. Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
Parlane NA; Grage K; Lee JW; Buddle BM; Denis M; Rehm BH
Appl Environ Microbiol; 2011 Dec; 77(24):8516-22. PubMed ID: 21984246
[TBL] [Abstract][Full Text] [Related]
16. Extracellular overproduction of E7 oncoprotein of Iranian human papillomavirus type 16 by genetically engineered Lactococcus lactis.
Mohseni AH; Taghinezhad-S S; Keyvani H; Razavilar V
BMC Biotechnol; 2019 Jan; 19(1):8. PubMed ID: 30678667
[TBL] [Abstract][Full Text] [Related]
17. Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12.
Bermúdez-Humarán LG; Cortes-Perez NG; Ah-Leung S; Lefèvre F; Yang G; Pang Q; Wu C; Zeng Y; Adel-Patient K; Langella P
J Mol Microbiol Biotechnol; 2008; 14(1-3):80-9. PubMed ID: 17957114
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
19. Expression of biologically active murine interleukin-18 in Lactococcus lactis.
Feizollahzadeh S; Khanahmad H; Rahimmanesh I; Ganjalikhani-Hakemi M; Andalib A; Sanei MH; Rezaei A
FEMS Microbiol Lett; 2016 Nov; 363(21):. PubMed ID: 27864297
[TBL] [Abstract][Full Text] [Related]
20. Alloantigen-reactive Th1 development in IL-12-deficient mice.
Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
